WOCKPHARMA.NS Overview

Company Profile

Related stocks

GLAND.NS • India

GLAND PHARMA LIMITED

3,061.8 INR

5.22B USD 1Y +57.3%

RGC • Hong Kong SAR China

Regencell Bioscience Holdings L

7.35 USD

3.64B USD 1Y -60.7%

0867.HK • Hong Kong SAR China

CMS

10.54 HKD

3.27B USD 1Y -23.9%

PPLPHARMA.NS • India

PIRAMAL PHARMA LIMITED

196.88 INR

2.7B USD 1Y -0.4%

COHANCE.NS • India

COHANCE LIFESCIENCES LTD

441 INR

1.74B USD 1Y -48.6%

688185.SS • China

CANSINO BIOLOGICS INC

98.46 CNY

3.64B USD 1Y +25.7%

NEULANDLAB.BO • India

NEULAND LABORATORIES LTD.

20,879.85 INR

2.77B USD 1Y +35.8%

CAPLIPOINT.BO • India

CAPLIN POINT LABORATORIES LTD.

2,459.55 INR

1.93B USD 1Y +27.1%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

India

Region

Asia-Pacific

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

49.8% p.a.

Max Drawdown (5Y)

-67.0%

Sharpe Ratio (5Y)

0.65

Beta Factor

1.00

Size Class

Mega Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 High valuation risk: Avg P/E of 79.3 (Elevated multiple compression risk)

Elevated Short-Term Volatility: 3Y volatility (55.2%) is noticeably higher than the 5Y average (49.8%).

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (49.8% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -84.3% in the extended horizon.